Lansforsakringar Fondforvaltning Ab (Publ) Bristol Myers Squibb CO Transaction History
Lansforsakringar Fondforvaltning Ab (Publ)
- $17 Billion
- Q2 2025
A detailed history of Lansforsakringar Fondforvaltning Ab (Publ) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lansforsakringar Fondforvaltning Ab (Publ) holds 740,997 shares of BMY stock, worth $34.6 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
740,997
Previous 769,404
3.69%
Holding current value
$34.6 Million
Previous $46.9 Million
26.9%
% of portfolio
0.2%
Previous 0.3%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,666Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA196MShares$9.14 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.4 Billion0.15% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.42 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.02 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.3 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.1B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...